Gregory Douglas, Baigelman Walter, Wilson Ira B
Tufts-New England Medical Center, Boston, MA 02111, USA.
Health Serv Res. 2003 Jun;38(3):905-18; discussion 919-22. doi: 10.1111/1475-6773.00152.
To determine the economic impact on the hospital of a hospitalist program and to develop insights into the relative economic importance of variables such as reductions in mean length of stay and cost, improvements in throughput (patients discharged per unit time), payer methods of reimbursement, and the cost of the hospitalist program.
The primary data source was Tufts-New England Medical Center in Boston. Patient demographics, utilization, cost, and revenue data were obtained from the hospital's cost accounting system and medical records.
The hospitalist admitted and managed all patients during a six-week period on the general medical unit of Tufts-New England Medical Center. Reimbursement, cost, length of stay, and throughput outcomes during this period were contrasted with patients admitted to the unit in the same period in the prior year, in the preceding period, and in the following period.
The hospitalist group compared with the control group demonstrated: length of stay reduced to 2.19 days from 3.45 days (p<.001); total hospital costs per admission reduced to 1,775 dollars from 2,332 dollars (p<.001); costs per day increased to 811 dollars from 679 dollars (p<.001); no differences for readmission within 30 days of discharge to extended care facilities. The hospital's expected incremental profitability with the hospitalist was -1.44 dollars per admission excluding incremental throughput effects, and it was most sensitive to changes in the ratio of per diem to case rate reimbursement. Incremental throughput with the hospitalist was estimated at 266 patients annually with an associated incremental profitability of 1.3 million dollars.
Hospital interventions designed to reduce length of stay, such as the hospitalist, should be evaluated in terms of cost, throughput, and reimbursement effects. Excluding throughput effects, the hospitalist program was not economically viable due to the influence of per diem reimbursement. Throughput improvements occasioned by the hospitalist program with high baseline occupancy levels are substantial and tend to favor a hospitalist program.
确定住院医师项目对医院的经济影响,并深入了解诸如平均住院时间和成本降低、吞吐量(单位时间内出院患者数量)改善、支付方报销方式以及住院医师项目成本等变量的相对经济重要性。
主要数据来源是波士顿的塔夫茨新英格兰医疗中心。患者人口统计学、利用率、成本和收入数据来自医院的成本核算系统和病历。
在塔夫茨新英格兰医疗中心普通内科病房的六周时间里,住院医师负责收治和管理所有患者。将此期间的报销、成本、住院时间和吞吐量结果与上一年同期、前一时期和下一时期该病房收治的患者进行对比。
与对照组相比,住院医师组的情况如下:住院时间从3.45天降至2.19天(p<0.001);每次入院的总医院成本从2332美元降至1775美元(p<0.001);每日成本从679美元增至811美元(p<0.001);出院后30天内再次入住长期护理机构的情况无差异。不考虑吞吐量增加的影响,医院采用住院医师项目预计每次入院的增量盈利能力为-1.44美元,且对每日费用与病例费率报销比例的变化最为敏感。估计住院医师带来的增量吞吐量为每年266例患者,相关的增量盈利能力为130万美元。
旨在缩短住院时间的医院干预措施,如住院医师项目,应从成本、吞吐量和报销影响方面进行评估。不考虑吞吐量影响,由于每日费用报销的影响,住院医师项目在经济上不可行。住院医师项目在高基线占用水平下带来的吞吐量改善相当可观,且倾向于支持住院医师项目。